MALIGNANT RETROPERITONEAL NEOPLASM

Clinical trials for MALIGNANT RETROPERITONEAL NEOPLASM explained in plain language.

Never miss a new study

Get alerted when new MALIGNANT RETROPERITONEAL NEOPLASM trials appear

Sign up with your email to follow new studies for MALIGNANT RETROPERITONEAL NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New combo attack on rare abdominal cancer before surgery

Disease control Ongoing

This early-stage study is testing the safety and best dose of a chemotherapy drug called eribulin when given with radiation therapy before surgery. It involves 15 patients with a rare abdominal cancer called retroperitoneal liposarcoma. The goal is to see if this combined approac…

Matched conditions: MALIGNANT RETROPERITONEAL NEOPLASM

Phase: PHASE1 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control

Last updated Mar 30, 2026 14:30 UTC

MALIGNANT RETROPERITONEAL NEOPLASM

Get alerted when new MALIGNANT RETROPERITONEAL NEOPLASM trials appear

New combo attack on rare abdominal cancer before surgery